These findings support a potential paracrine role for VAT in mediating endothelial dysfunction through the impairment of Kir2.1; however, the link between VAT and endothelial CD36 upstream of Kir2.1 impairment is yet to be established. The gene discussed is CD36; the disease is endothelial dysfunction.